MeSH tree: D26.528
From headlines and social media, psychedelic therapies, cannabis use and GLP-1 medications have seemingly become commonplace overnight, but the science underlying these treatments and the pathway to drug approval are often ...
Jul 20, 2026
0
6
As the U.S. Drug Enforcement Administration (DEA) gears up for its administrative hearing on the fate of federal marijuana legalization, UNLV Cannabis Policy Institute (CPI) director Riana Durrett offers a rundown on decades ...
Jun 23, 2026
0
10
Young people who use cannabis daily are up to four times more likely to develop psychosis than those who don't, according to an international study led by University of Queensland researchers. The review analyzed evidence ...
Jun 18, 2026
0
13
When the U.S. Department of Justice moved to reclassify medical marijuana to a Schedule III drug on April 23, 2026, it set the stage for a vast amount of medical research that has been hobbled for decades by its more restrictive ...
Apr 29, 2026
0
6
Most people strongly support the federal government's reclassification of cannabis, according to a new study that used AI to analyze more than 40,000 comments in the public record. The findings by researchers at Johns Hopkins ...
Apr 29, 2026
0
7
The proportion of people diagnosed with and treated for attention-deficit hyperactivity disorder (ADHD) is growing. Prescription rates have increased 11-fold in 20 years.
Apr 22, 2026
0
4
In the past 10 years or so, there has been a lot of interest to see if medicinal cannabis can help children with emotional and behavioral problems—the ones associated with conditions such as autism, ADHD (attention-deficit ...
Apr 7, 2026
0
4
Anxiety, depression and post-traumatic stress disorder (PTSD) are among the most common mental health conditions for which Australians are prescribed medicinal cannabis.
Apr 1, 2026
0
3
Your doctor has just prescribed medicinal cannabis. You think it's helping. But you rely on your car to get to work and pick up the kids.
Mar 30, 2026
0
5
A landmark paper published in Lancet Psychiatry—the largest-ever review of the safety and efficacy of cannabinoids across a range of mental health conditions—found no evidence that medicinal cannabis is effective in treating ...
Mar 16, 2026
0
34
